COMORBIDITY OF AFFECTIVE DISORDERS AND METABOLIC SYNDROME AMONG ADULT POPULATION OF KRASNOYARSK
https://doi.org/10.29001/2073-8552-2016-31-4-65-68
Abstract
The purpose of this study was to assess relationships between metabolic syndrome (MS) and depressive disorders (DD) among adult population in Krasnoyarsk taking into account gender identity. Materials and Methods. We analyzed data of 1123 subjects aged 25–34 years who participated in the study titled “Epidemiology of Cardio
Vascular Diseases in Russian Federation – 2012”. We studied the levels of depression according to hospital anxiety and depression scale (HADS); indicators of metabolic syndrome (MS) were assessed according to the criteria of Adult Treatment Panel III (ATP III); the relationships between depressive disorders and MS were evaluated. Results. The frequency of MS among adult population of Krasnoyarsk was 23% (20.5% among men and 24.4% among women). Men with and without MS equally often had subclinical depression and clinical depression (15.5% vs. 13.3% for subclinical depression and 3.6% vs. 4.0% for clinical depression). In women with MS, depressive disorders were diagnosed significantly more often in comparison with women without MS (23.3% vs. 16.3% for higher level of depression, p=0.038 and 7.6% vs 3.7% for clinical depression, p=0.039). In addition, among women with components of MS such as abdominal obesity (AO) and increased blood pressure (IBP), the prevalence of subclinical depression was significantly higher in comparison with women without AO and IBP. Conclusions. General practitioners should give special attention to women with MS, since depressive disorders are more common in this group of patients. In women, such MS components as AO and IBP are associated with depressive disorders. Timely diagnosis of depressive disorders among women with MS can have a positive impact on adherence to MS therapy, thereby reducing overall cardiovascular risk.
About the Authors
R. D. Peskovets
Krasnoyarsk State Medical University n.a. Prof. V.F. Voyno9Yasenetsky
Russian Federation
Russian Federation
S. Yu. Shtarik
Krasnoyarsk State Medical University n.a. Prof. V.F. Voyno9Yasenetsky
Russian Federation
Russian Federation
A. A. Evsyukov
Krasnoyarsk State Medical University n.a. Prof. V.F. Voyno9Yasenetsky
Russian Federation
Russian Federation
References
1. Гарганеева Н.П., Тетенев Ф.Ф., Семке В.Я. Артериальная гипертония как психосоматическая проблема // Клинич. медицина. – 2004. – Т. 82, № 1. – С. 35–41.
2. Никитин Ю.П., Казека Г.Р., Симонова Г.И. Распространенность компонентов метаболического синдрома X в неорганизованной городской популяции (эпидемиологическое исследование) // Кардиология. – 2001. – Т. 9. – С. 37–40.
3. Оздоева Л.Д., Небиеридзе Д.В., Погосова Г.В. и др. Взаимосвязь факторов риска атеросклероза и тревожно-депрессивных состояний у мужчин из неорганизованной популяции // Кардиоваск. терапия и профилактика. – 2003. – № 2 (1). – С. 59–64.
4. Песковец Р.Д., Штарик С.Ю., Евсюков А.А. и др. Анализ распространенности артериальной гипертензии среди взрослого населения крупного промышленного города Восточной Сибири // Современные тенденции развития науки и технологий. – 2016. – Т. 130, № 5. – С. 24–29.
5. Штарик С.Ю., Петрова М.М., Гарганеева Н.П. Некоторые аспекты коморбидности тревожно-депрессивных расстройств и артериальной гипертензии // Сиб. мед. журн. (Томск). – 2009. – Т. 24, № 4–2. – С. 46–48.
6. Штарик С.Ю., Петрова М.М., Гарганеева Н.П. Предикторы ОНМК и летальных исходов с позиции биопсихосоциального подхода (популяционное исследование) // CardioСоматика. – 2014. – Т. 5, № 1. – С. 20–23.
7. Штарик С.Ю., Петрова М.М., Гарганеева Н.П. Эпидемиология тревожно-депрессивных расстройств среди взрослого населения крупного индустриального города Восточной Сибири // Сиб. вестн. психиатрии и наркологии. – 2009. – Т. 57, № 6. – С. 18–22.
8. Alexander C.M., Landsman P.B., Teutsch S.M. NCEP – defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older // Diabetes. – 2003. – Vol. 52, No. 5. – P. 1210–1214.
9. Carney R.M., Freedland K.E., Miller G.E. Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms // J. psychosomatic res. – 2002. – Vol. 53, No. 4. – P. 897–902.
10. Deepa R., Shanthirani C.S., Premalatha G. et al. Prevalence of insulin resistance syndrome in a selected south Indian population – the Chennai urban population study 7 [CUPS 7] // Ind. J. Med. Res. – 2002. – Vol. 115. – P. 118–127.
11. Gami A.S., Witt B.J., Howard O.E. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta analysis of longitudinal studies // J. Am. Coll. Cardiology. – 2007. – Vol. 49, No. 4. – P. 403–414.
12. Khoo C.M., Liew C.F., Chew S. et al. The impact of central obesity as a prerequisite for the diagnosis of metabolic syndrome // Obesity. – 2007. – Vol. 15, No. 1. – P. 262–269.
13. Moebus S., Stang A. The metabolic syndrome – a controversial diagnostic concept // Herz. – 2007. – Vol. 32, No. 7. – P. 529–540.
14. Ostchega Y., Yoon S.S., Hughes J. et al. Hypertension awareness, treatment, and control – continued disparities in adults: United States, 2005–2006 // NCHS data brief. – 2008. – No. 3. – P. 1– 8.
15. Skilton M.R. Moulin P., Terra J.L. et al. Associations between anxiety, depression, and the metabolic syndrome // Biologic. psychiatry. – 2007. – Vol. 62, No. 11. – P. 1251–1257.
16. Sy R.G. Metabolic syndrome in Asia: time for action // MesS Insights. – 2006. – Vol. 9. – P. 4–7.
17. Toker S., Shirom A., Melamed S. Depression and the metabolic syndrome: gender dependent associations // Depression and anxiety. – 2008. – Vol. 25, No. 8. – P. 661–669.
18. Vasan R.S. Larson M.G., Leip E.P. et al. Assessment of frequency of progression to hypertension in non hypertensive participants in the Framingham Heart Study: a cohort study // Lancet. – 2001. – Vol. 358, No. 9294. – P. 1682–1686.
Review
For citations:
Peskovets R.D., Shtarik S.Yu., Evsyukov A.A. COMORBIDITY OF AFFECTIVE DISORDERS AND METABOLIC SYNDROME AMONG ADULT POPULATION OF KRASNOYARSK. Siberian Journal of Clinical and Experimental Medicine. 2016;31(4):65-68. (In Russ.) https://doi.org/10.29001/2073-8552-2016-31-4-65-68
Views:
322
.png)
Email this article 